HIGHLIGHTS
- who: Daniel H. Solomon from the Road, Boston, MA, USA have published the Article: The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy, in the Journal: (JOURNAL)
- what: Since many patients find using monotherapy preferable, the authors focused on TCZm and examined the sequences to and predictors of its use in a large real-world dataset from the US, Corrona. The authors focused on predictors of TCZm in longitudinal analyses . While this study did not aim to define which treatments are best for a given set of patients, the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.